en
Pink October & Breast Health Awareness
Understand Malaysia’s breast cancer statistics, warning signs, risk factors, self-examination steps and recommended screening pathway.
Pink October serves as a vital yearly reminder that breast cancer remains a primary health threat facing Malaysian women. Data from the Malaysian National Cancer Registry Report (MNCRR 2017–2021) indicates that breast cancer accounts for 32.9% of all female cancer diagnoses in Malaysia nearly one in three cancers detected in women.
Despite advancements in medical technology, late-stage presentation continues to be a major health challenge nationwide. Understanding local health statistics, recognising demographic variations across Malaysian communities and committing to timely screening can significantly influence treatment outcomes.
Breast Cancer in Malaysia: Key Facts and National Statistics
Breast cancer in Malaysia exhibits distinct characteristics compared with patterns observed in Western nations, alongside notable variations among local ethnic groups.
~50%
Younger Age at Diagnosis
MOH data indicates that roughly half of Malaysian breast cancer patients are diagnosed before age 50, compared with about 20% in Western countries.
1 in 23
Lifetime Risk
Approximately one in 23 Malaysian women will receive a breast cancer diagnosis in their lifetime.
50.5%
Late-Stage Diagnosis
More than half of new cases are diagnosed at Stage 3 or Stage 4, affecting long-term survival.
87.5% vs 23.3%
Five-Year Survival
MySCan reports five-year relative survival of 87.5% for Stage 1 and 23.3% for Stage 4 breast cancer.
Comprehensive Ethnic Breakdown of Breast Cancer in Malaysia
The Ministry of Health categorises Malaysian cancer data into four primary national ethnic classifications: Chinese, Indian, Malay and Other Bumiputera. The latter encompasses East Malaysian indigenous communities such as Kadazan-Dusun, Bajau and Murut in Sabah; Iban, Bidayuh and Melanau in Sarawak; and Peninsular Orang Asli.
Data from the MNCRR and MySCan highlights a contrast between which groups develop the disease more frequently and which experience poorer survival outcomes associated with late-stage detection.
| Ethnic Classification | Specific Subgroups | Lifetime Risk & Incidence | Diagnostic Pattern | Five-Year Relative Survival |
|---|---|---|---|---|
| Chinese | Peninsular and East Malaysian Chinese | Highest reported incidence; 1 in 19 lifetime risk | Higher proportion of early-stage detection | ~64.7% |
| Indian | Peninsular Indian community | Second-highest reported incidence; 1 in 17 lifetime risk | Mixed early- and late-stage presentation | ~59.8% |
| Malay | Peninsular and East Malaysian Malay | Lower incidence; 1 in 27 lifetime risk | Disproportionate Stage 3 and Stage 4 presentation | ~52.7% |
| Other Bumiputera | Kadazan-Dusun, Iban, Bidayuh, Bajau, Melanau, Murut and Orang Asli | 8.6% of national cancer cases; predominant in Sabah and Sarawak | High late-stage presentation associated with rural access barriers | Reported as comparable to Malay rates due to delayed clinical access |
Key Demographic Insights
- - Highest incidence among Chinese women: Chinese women record the highest age-standardised incidence rate in Malaysia. Clinical research associates this partly with dense breast tissue and reproductive lifestyle factors, such as later age at first childbirth.
- - Late presentation among Malay women: Although Malay women have a lower overall statistical risk, they are disproportionately diagnosed at Stage 3 or Stage 4. Fear, social stigma and reliance on unverified alternative treatment before professional consultation may contribute to delays.
- - Geographic challenges for East Malaysian indigenous groups: Breast cancer remains the leading female cancer in Sabah and Sarawak. Rural dispersion and travel distances to tertiary centres can delay clinical presentation.
Early Signs and Symptoms: What to Look Out For
Early-stage breast cancer may not cause noticeable discomfort. Breast awareness and regular checks help you recognise changes that should be assessed by a healthcare professional.
A New Lump or Thickening
A firm, painless mass in the breast tissue or underarm area.
Changes in Size or Shape
Unexplained swelling, shrinkage or asymmetry between breasts.
Skin Changes
Dimpling, puckering or redness resembling orange-peel texture (peau d’orange).
Nipple Changes
Nipple inversion, persistent soreness, scaling or peeling around the areola.
Nipple Discharge
Spontaneous discharge, particularly if clear or bloody.
A breast symptom or lump does not automatically mean cancer. Many investigated lumps are benign, including fibroadenomas and fluid-filled cysts, but prompt clinical evaluation remains essential.
Are all breast symptoms a sign of cancer?
No. Temporary changes may relate to hormonal fluctuations, fibrocystic breast changes, fibroadenomas or mastitis. Any new, unexplained or persistent symptom should still be evaluated through clinical examination and appropriate diagnostic imaging.
Step-by-Step Breast Self-Examination Guide at Home
Monthly breast self-examination helps you become familiar with the normal look and feel of your breasts. The suggested time is seven to ten days after your menstrual period begins, when the breasts are less likely to be tender or swollen.
STEP 1
Visual Check in the Mirror
Stand with your shoulders straight and hands on your hips. Look for changes in size, shape or colour, skin dimpling or puckering, and nipple inversion.
STEP 2
Visual Check with Raised Arms
Raise both arms overhead and view the breasts from the front and sides. Note the same visual changes or uneven movement.
STEP 3
Physical Check Standing
Use the pads of your three middle fingers. Move in firm circles from the outer edge towards the nipple, covering the breast and armpit.
STEP 4
Physical Check Lying Down
Place a pillow beneath one shoulder and the same-side arm behind your head. Use the opposite hand with light, medium and firm pressure. Repeat on the other side and check for unexpected nipple discharge.
Breast self-examination supports awareness but does not replace clinical assessment or screening mammography.
Risk Factors: Who Is Most at Risk?
Any woman can develop breast cancer, but certain factors may increase individual risk:
- - Age and gender: Being female and advancing in age remain major risk factors.
- - Family history and genetics: Inherited mutations such as BRCA1 and BRCA2, or a family history of breast or ovarian cancer, can increase risk.
- - Dense breast tissue: Dense breasts are associated with greater risk and may require supplemental assessment beyond conventional mammography.
- - Hormonal factors: Early menstruation, late menopause or prolonged postmenopausal hormone therapy may affect risk.
- - Lifestyle factors: Physical inactivity, postmenopausal obesity and regular alcohol consumption are relevant considerations.
Recommended Breast Screening Guidelines for Malaysians
Early detection can identify breast cancer when treatment options may be more effective. Screening recommendations should be personalised according to age, symptoms, family history, breast density and clinical risk.
AGES 20–39
Breast Awareness and Clinical Examination
Perform monthly self-checks seven to ten days after menstruation begins. Consider a clinical breast examination by a trained doctor or nurse every one to three years.
AGES 40–49
Individual Risk Assessment
Discuss your family history and individual risk factors with a doctor to determine whether annual mammography is appropriate.
AGES 50–74
Routine Mammography
Consider screening mammography every one to two years. Mammography can detect non-palpable changes before physical symptoms appear.
Frequently Asked Questions
Is a breast lump always cancerous?
No. According to clinical guidance from the Mayo Clinic Health System and the MOH Clinical Practice Guidelines, over 80% of breast lumps investigated turn out to be benign conditions, such as fibroadenomas or fluid-filled cysts. However, any new lump should be evaluated promptly by a medical professional to rule out malignancy.
Is breast pain usually a sign of breast cancer?
Breast pain (mastalgia) is rarely the primary symptom of breast cancer. Most breast pain is cyclic and tied to hormonal shifts during menstrual cycles or benign breast conditions. However, localised, continuous pain that affects one specific area should be examined by a specialist, following the Mayo Clinic Patient Care Guidelines.
Can a breast ultrasound replace a screening mammogram?
A breast ultrasound does not replace a screening mammogram. According to the MNCRR Report and Mayo Clinic Breast Density Guidance, mammograms remain the gold standard for detecting early microcalcifications that ultrasound may miss. However, ultrasound is an essential complementary diagnostic tool, particularly for women with dense breast tissue or to further evaluate a targeted lump identified during physical examination or mammography.
Does a mammogram hurt?
A mammogram involves pressing the breast tissue between two plates for a few seconds to obtain clear imaging. As highlighted in the MOH Public Health Advisory and by Cancer Research Malaysia, while it can cause mild pressure or temporary discomfort, it is quick, safe, and necessary for accurate readings.
Can men get breast cancer?
Yes. Although rare, male breast cancer accounts for under 1% of all breast cancer cases globally. Men should consult a doctor if they notice a lump or skin changes around the chest area.
Where can I get screened in Malaysia?
Screening facilities are available at public health clinics, government hospitals under the MOH Cancer Control Division, non-governmental organisations, and private medical centres across Malaysia, such as the KPJ Healthcare Network.
Take Charge of Your Breast Health with KPJ Healthcare
This Pink October, do not delay recommended health checks. KPJ Healthcare provides breast health services through its nationwide network of specialist hospitals, supported by multidisciplinary oncology teams and breast health services across Peninsular Malaysia, Sabah and Sarawak.
- 3D digital mammography (tomosynthesis) for clearer imaging, including in dense breasts
- High-resolution breast ultrasound and magnetic resonance imaging (MRI)
- Fine-needle aspiration and core-needle biopsy
- Multidisciplinary oncology care tailored to individual needs
Book a Breast Screening Consultation
Explore KPJ breast screening packages or speak directly with the care team to arrange an appointment.
References and Sources
- National Cancer Registry Department, Ministry of Health Malaysia: Malaysian National Cancer Registry Report 2017–2021. Putrajaya: National Cancer Institute.
- National Cancer Institute, Ministry of Health Malaysia: Malaysian Study on Cancer Survival (MySCan).
- Mayo Clinic: Breast cancer symptoms, causes, risk factors and diagnosis guidance.
- Cancer Research Malaysia: Asian-specific breast cancer risk assessment and genetic profiling studies.
- Department of Statistics Malaysia: Statistics on Causes of Death, Malaysia.
This article provides general educational information and does not replace medical advice, diagnosis or treatment. Screening recommendations and investigations should be discussed with a qualified healthcare professional based on individual risk and symptoms.
.png)
